Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives
Journal of Pathology and Translational Medicine
;
: 224-241, 2017.
Artículo
en Inglés
| WPRIM
| ID: wpr-38102
ABSTRACT
Molecular pathologic testing plays an important role for the diagnosis, prognostication and decision of treatment strategy in lymphoproliferative disease. Here, we briefly review the molecular tests currently used for lymphoproliferative disease and those which will be implicated in clinical practice in the near future. Specifically, this guideline addresses the clonality test for B- and T-cell proliferative lesions, molecular cytogenetic tests for malignant lymphoma, determination of cell-of-origin in diffuse large B-cell lymphoma, and molecular genetic alterations incorporated in the 2016 revision of the World Health Organization classification of lymphoid neoplasms. Finally, a new perspective on the next-generation sequencing for diagnostic, prognostic, and therapeutic purpose in malignant lymphoma will be summarized.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Organización Mundial de la Salud
/
Linfocitos T
/
Linfoma de Células B
/
Clasificación
/
Hibridación Fluorescente in Situ
/
Citogenética
/
Diagnóstico
/
Patología Molecular
/
Linfoma
/
Trastornos Linfoproliferativos
Tipo de estudio:
Estudio diagnóstico
/
Guía de Práctica Clínica
/
Estudio pronóstico
Idioma:
Inglés
Revista:
Journal of Pathology and Translational Medicine
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS